Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
5,108.05
5,131.44
4,042.81
3,819.98
4,388.18
5,370.43
5,158.19
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
5,108.05
5,131.44
4,042.81
3,819.98
4,388.18
5,370.43
5,158.19
Raw Material Cost
2,792.40
2,777.97
2,191.27
2,038.70
2,683.69
2,973.31
2,876.56
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
656.87
651.11
624.51
566.01
480.73
505.44
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
62.51
78.87
86.46
93.81
79.76
75.53
72.99
Selling and Distribution Expenses
1,535.53
1,614.78
1,498.39
1,400.61
1,223.62
1,033.67
986.05
Other Expenses
-44.23
-45.25
-41.42
-48.17
-37.38
-26.61
12.91
Total Expenditure (Excl Depreciation)
4,604.99
4,670.21
3,986.44
3,617.42
4,093.97
4,321.89
4,064.75
Operating Profit (PBDIT) excl Other Income
503.1
461.2
56.4
202.60000000000002
294.20000000000005
1048.5
1093.4
Other Income
99.32
177.40
84.98
184.39
67.34
126.72
151.55
Operating Profit (PBDIT)
902.84
912.87
374.25
592.51
553.96
1,341.18
1,375.89
Interest
62.51
78.87
86.46
93.81
79.76
75.53
72.99
Exceptional Items
-27.76
-67.90
-857.77
-85.92
-32.13
1.39
-69.32
Gross Profit (PBDT)
2,315.65
2,353.47
1,851.54
1,781.28
1,704.49
2,397.13
2,281.63
Depreciation
362.28
345.60
279.82
237.91
212.95
186.44
161.49
Profit Before Tax
450.28
420.38
-849.80
174.87
229.13
1,080.60
1,072.08
Tax
50.25
65.04
16.62
29.65
-31.42
149.32
195.07
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
402.02
385.97
-551.07
191.22
278.40
968.39
903.47
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
402.02
385.97
-551.07
191.22
278.40
968.39
903.47
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-28.57
-62.35
-334.58
-64.13
-36.18
-37.00
-30.35
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
373.45
323.62
-885.65
127.09
242.21
931.39
873.12
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
0.0
Reserves
8,834.53
8,521.87
8,275.63
8,812.04
8,535.17
8,430.50
7,499.56
Earnings per share (EPS)
0.33
0.32
-0.45
0.15
0.23
0.79
0.74
Diluted Earnings per share
0.33
0.32
-0.45
0.15
0.23
0.79
0.74
Operating Profit Margin (Excl OI)
8.64%
7.6%
0.23%
4.46%
6.24%
19.14%
20.6%
Gross Profit Margin
15.91%
14.93%
-14.1%
10.81%
10.07%
23.59%
23.91%
PAT Margin
7.87%
7.52%
-13.63%
5.01%
6.34%
18.03%
17.52%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is -0.46% vs 26.93% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 15.42% vs 136.54% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 9.25% vs 154.23% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -20.79% vs -8.79% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Yifan Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
5,108.05
0
5,108.05
Other Operating Income
0.00
0.00
0.00
Total Operating income
5,108.05
0
5,108.05
Raw Material Cost
2,792.40
0
2,792.40
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
656.87
0
656.87
Power Cost
0
0
0.00
Manufacturing Expenses
62.51
0
62.51
Selling and Distribution Expenses
1,535.53
0
1,535.53
Other Expenses
-44.23
0.00
-44.23
Total Expenditure (Excl Depreciation)
4,604.99
0
4,604.99
Operating Profit (PBDIT) excl Other Income
503.05
0.00
503.05
Other Income
99.32
0
99.32
Operating Profit (PBDIT)
902.84
0
902.84
Interest
62.51
0
62.51
Exceptional Items
-27.76
0
-27.76
Gross Profit (PBDT)
2,315.65
0
2,315.65
Depreciation
362.28
0
362.28
Profit Before Tax
450.28
0
450.28
Tax
50.25
0
50.25
Provisions and contingencies
0
0
0.00
Profit After Tax
402.02
0
402.02
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
402.02
0
402.02
Share in Profit of Associates
0
0
0.00
Minority Interest
-28.57
0
-28.57
Other related items
0.00
0.00
0.00
Consolidated Net Profit
373.45
0
373.45
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
8,834.53
0
8,834.53
Earnings per share (EPS)
0.33
0
0.33
Diluted Earnings per share
0.33
0
0.33
Operating Profit Margin (Excl OI)
8.64%
0%
0.00
8.64%
Gross Profit Margin
15.91%
0%
0.00
15.91%
PAT Margin
7.87%
0%
0.00
7.87%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 510.80 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -0.46% vs 26.93% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 37.35 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 15.42% vs 136.54% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 80.35 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 9.25% vs 154.23% in Dec 2024
Annual - Interest
Interest 6.25 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -20.79% vs -8.79% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 8.64%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






